MedPath

LACOSAMIDE

These highlights do not include all the information needed to use LACOSAMIDE INJECTION safely and effectively. See full prescribing information for LACOSAMIDE INJECTION. LACOSAMIDE injection, for intravenous use, CV Initial U.S. Approval: 2008

Approved
Approval ID

01162e2f-967b-4596-8188-c0d9889c3814

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 13, 2023

Manufacturers
FDA

Virtus Pharmaceuticals, LLC

DUNS: 079659493

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LACOSAMIDE

PRODUCT DETAILS

NDC Product Code69543-455
Application NumberANDA215628
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJanuary 1, 2023
Generic NameLACOSAMIDE

INGREDIENTS (4)

LACOSAMIDEActive
Quantity: 10 mg in 1 mL
Code: 563KS2PQY5
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LACOSAMIDE - FDA Drug Approval Details